Skip to content

Early Versus Delayed Laparoscopic Cholecystectomy for Acute Cholecystitis

Early Versus Delayed Laparoscopic Cholecystectomy for Acute Cholecystitis: A Prospective Study Adjusting for Confounding by Indication

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07101315
Acronym
EDLC-AC
Enrollment
81
Registered
2025-08-03
Start date
2022-01-01
Completion date
2023-12-30
Last updated
2025-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Cholecystitis

Keywords

Laparoscopic Cholecystectomy, Gallstones, Biliary Disease, Surgical Timing

Brief summary

The goal of this clinical trial is to learn if performing gallbladder surgery early is as safe and effective as delaying it for people with acute cholecystitis (a sudden gallbladder infection). The main questions it aims to answer are: * Do participants who have early surgery have a similar rate of complications compared to those who have delayed surgery? * How does the timing of surgery affect the length of the hospital stay? Researchers will compare two groups: 1. An early surgery group 2. A delayed surgery group Participants in the early surgery group had their gallbladder removed within 72 hours of when their symptoms started. Participants in the delayed surgery group were first treated with medications and had their surgery 6-8 weeks later.

Interventions

PROCEDURELaparoscopic Cholecystectomy

Standard four-port laparoscopic cholecystectomy was performed by a specialist or resident surgeon.

Sponsors

Al-Thawra Modern General Hospital
CollaboratorOTHER
Al-Kuwait University Hospital
CollaboratorUNKNOWN
Sana'a University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Yemeni nationals aged 18-70 years * A clinical diagnosis of acute cholecystitis confirmed by clinical presentation, laboratory findings, and imaging studies * Symptom duration of less than 72 hours at presentation * Fitness for general anesthesia (American Society of Anesthesiologists \[ASA\] physical status classification I-III) * Provision of written informed consent

Exclusion criteria

* Evidence of choledocholithiasis or acute cholangitis * Severe comorbidities precluding surgery (ASA class IV-V) * Coagulopathy (INR \>1.5 or platelet count \<100,000/μL) * Pregnancy * Previous major upper abdominal surgery * Patient refusal to participate

Design outcomes

Primary

MeasureTime frameDescription
Overall Postoperative ComplicationsWithin 30 days post-surgeryIncidence of any postoperative complication within 30 days
Conversion to Open SurgeryIntraoperativeRate of conversion from laparoscopic to open cholecystectomy during the procedure.
Operative TimeIntraoperativeDuration of surgery, measured in minutes from skin incision to skin closure.

Secondary

MeasureTime frameDescription
Postoperative Length of Hospital StayUp to 30 days post-surgeryNumber of days from surgery to hospital discharge.
30-Day Readmission Rate30 daysRate of unplanned hospital readmission for any cause within 30 days of discharge.
Duration of Postoperative PainUp to 30 days post-surgeryNumber of days from surgery until the participant was free of the need for analgesic medication.
Time to Return to Normal Daily ActivitiesUp to 30 days post-surgeryNumber of days from surgery until the participant reported a full return to normal daily activities.

Countries

Yemen

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026